Literature DB >> 22799343

Overexpression of cyclin L2 inhibits growth and enhances chemosensitivity in human gastric cancer cells.

Hong-Li Li1, Ding-Zhi Huang, Ting Deng, Li-Kun Zhou, Xia Wang, Ming Bai, Yi Ba.   

Abstract

Cyclin L2 is a novel member of the cyclin family, recently implicated in the regulation of cell cycle progression and/or transcriptional regulation. The present study was undertaken to investigate the effects of overexpression on tumor cell growth and chemosensitivity in human gastric cells in vitro. Cyclin L2 was transfected into human gastric cancer cell line BCG823 and expressed with a mammalian expression vector pcDNA3.1. The effects and mechanisms of cyclin L2 on cell growth, cell cycling and apoptosis were studied. Compared to control vectors, overexpression of cyclin L2 inhibited the growth of BCG823 cells and enhance their chemosensitivity to fluorouracil, docetaxel and cisplatin. The anti-proliferative effects of cyclin L2 could be due to G0/G1 arrest and apoptosis. Cyclin L2 induced G0/G1 arrest and apoptosis involved upregulation of caspase-3 and down regulation Bcl-2 and survivin. The results indicated that overexpression of cyclin L2 protein may promote efficient growth inhibition and enhance chemosensitivity to chemotherapeutic agents in human gastric cancer cells by inducing G0/G1 cell cycle arrest and apoptosis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22799343     DOI: 10.7314/apjcp.2012.13.4.1425

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  5 in total

1.  Research and clinical applications of molecular biomarkers in gastrointestinal carcinoma (Review).

Authors:  Feng Jiao; Ziliang Jin; Lei Wang; Liwei Wang
Journal:  Biomed Rep       Date:  2013-08-20

2.  BAD, a Proapoptotic Protein, Escapes ERK/RSK Phosphorylation in Deguelin and siRNA-Treated HeLa Cells.

Authors:  Samra Hafeez; Mahwish Urooj; Shamiala Saleem; Zeeshan Gillani; Sumaira Shaheen; Mahmood Husain Qazi; Muhammad Imran Naseer; Zafar Iqbal; Shakeel Ahmed Ansari; Absarul Haque; Muhammad Asif; Manzoor Ahmad Mir; Ashraf Ali; Peter Natesan Pushparaj; Mohammad Sarwar Jamal; Mahmood Rasool
Journal:  PLoS One       Date:  2016-01-08       Impact factor: 3.240

3.  Upregulation of MicroRNA-214 Contributes to the Development of Vascular Remodeling in Hypoxia-induced Pulmonary Hypertension Via Targeting CCNL2.

Authors:  HaiTao Liu; Yin Tao; Mai Chen; Jin Yu; Wei-Jie Li; Ling Tao; Yan Li; Fei Li
Journal:  Sci Rep       Date:  2016-07-06       Impact factor: 4.379

4.  Uncovering the Translational Regulatory Activity of the Tumor Suppressor BRCA1.

Authors:  Elise Berthel; Anne Vincent; Lauriane Eberst; Adrian Gabriel Torres; Estelle Dacheux; Catherine Rey; Virginie Marcel; Hermes Paraqindes; Joël Lachuer; Frédéric Catez; Lluis Ribas de Pouplana; Isabelle Treilleux; Jean-Jacques Diaz; Nicole Dalla Venezia
Journal:  Cells       Date:  2020-04-10       Impact factor: 6.600

5.  Identification of novel cyclin gene fusion transcripts in endometrioid ovarian carcinomas.

Authors:  Antonio Agostini; Marta Brunetti; Ben Davidson; Claes Göran Tropé; Sverre Heim; Ioannis Panagopoulos; Francesca Micci
Journal:  Int J Cancer       Date:  2018-04-25       Impact factor: 7.396

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.